The Cooper Companies Q3 FY2026 results
$62.65+0.74%
The Cooper Companies reported revenue of $1.07 billion, up 0.6% from a year earlier, net income of $433 million and diluted earnings per share of $2.24 against $0.49 for the third quarter of fiscal 2026 (the three months to 31 Jul 2026).
From its quarterly report, filed 9 Sep 2026. Compiled and checked by AapWire.
Q3 FY2026 against Q3 FY2025
Three months to 31 Jul 2026, against the three months to 31 Jul 2025. Amounts in USD.
| Measure | Q3 FY2026 | Q3 FY2025 | Change |
|---|---|---|---|
| Revenue | $1.07B | $1.06B | +0.6% |
| Gross profit | $711.9M | $692.0M | +2.9% |
| Gross margin | 66.8% | 65.3% | +1.5 pts |
| Operating income | $222.0M | $175.7M | +26.4% |
| Operating margin | 20.8% | 16.6% | +4.3 pts |
| Net income | $432.8M | $98.30M | +340% |
| Diluted EPS | $2.24 | $0.49 | +357% |
| Operating cash flow | $341.7M | $261.4M | +30.7% |
| Capital expenditure | $68.70M | $96.90M | −29.1% |
| Free cash flow | $273.0M | $164.5M | +66.0% |
Operating KPIs for the quarter
| KPI | Q3 FY2026 | Change on a year |
|---|---|---|
| Toric and multifocal revenue | $363.8M | up 1.4% |
| Sphere, other revenue | $353.2M | down 1.8% |
| Office and surgical revenue | $208.0M | up 1.6% |
| Fertility revenue | $141.2M | up 3.0% |
| Coopervision Segment revenue | $717.0M | down 0.2% |
| CooperVision revenue | $717.0M | down 0.2% |
| Coopersurgical Segment revenue | $349.2M | up 2.1% |
| CooperSurgical revenue | $349.2M | up 2.1% |
| United States revenue | $519.5M | up 0.6% |
| Europe revenue | $357.5M | up 4.2% |
| Rest of world revenue | $189.2M | down 5.9% |
Earlier quarters
| Quarter | Period end | Revenue | Change on a year | Diluted EPS |
|---|---|---|---|---|
| Q3 FY2026 | 31 Jul 2026 | $1.07B | +0.6% | $2.24 |
| Q2 FY2026 | 30 Apr 2026 | $1.08B | +7.9% | −$0.40 |
| Q1 FY2026 | 31 Jan 2026 | $1.02B | +6.2% | $0.66 |
| Q4 FY2025 | 31 Oct 2025 | $1.07B | +4.6% | $0.43 |
| Q3 FY2025 | 31 Jul 2025 | $1.06B | +5.7% | $0.49 |
| Q2 FY2025 | 30 Apr 2025 | $1.00B | +6.3% | $0.44 |
| Q1 FY2025 | 31 Jan 2025 | $964.7M | +3.6% | $0.52 |
| Q4 FY2024 | 31 Oct 2024 | $1.02B | +9.8% | $0.59 |
More on The Cooper Companies: financial statements · revenue · earnings per share
COO's results, as they are filed.
Releases read within minutes, guidance against results, the quarter in its eight-quarter history, and an alert on each new report.
